In this episode of the Frontline Gastroenterology podcast, AACE President Scott D. Isaacs, MD, FACP, FACE, discusses the use of anti-diabetic medications such as pioglitazone or GLP-1 receptor agonists in the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Join Dr. Oliver Tavabie as he interviews Dr. Scott Isaacs and Dr. Paul Brennan to discuss key insights from their published paper, "Role of Anti-Diabetic Medications in the Management of MASLD."